Thirty-three patients with advanced colorectal adenocarcinoma were treated with daily Anguidine i.v. 5 mg/m2 X 5 for 3 weeks. The patients were stratified into two groups: prior chemotherapy and no prior chemotherapy. No responses were noted. Major toxicities were hypotension and fever.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00000421-198606000-00002 | DOI Listing |
Publication Analysis
Top Keywords
colorectal adenocarcinoma
8
prior chemotherapy
8
phase evaluation
4
evaluation anguidine
4
anguidine nsc
4
nsc 141537
4
141537 5-day
4
5-day courses
4
courses colorectal
4
adenocarcinoma southeastern
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!